InterMune

Wells Fargo Securities analysts Aaron Reames and Matthew J. Andrews rated shares of InterMune, Inc. (Nasdaq: ITMN) Market Perform. The analysts questioned whether or not the FDA would accept InterMune's use of Forced Vital Capacity, as opposed to Overall Survival as the appropriate endpoint for the...